Biosimilars

Explore approved biosimilar medicines

# Medicine Status Active Substance Therapeutic Area Developer Published Date
101 Obodence Authorised denosumab Osteoporosis, Postmenopausal;Osteoporosis;Bone Resorption Samsung Bioepis NL B.V. 15-11-2024
102 Junod Authorised denosumab Bone Resorption;Osteoporosis;Osteoporosis, Postmenopausal Gedeon Richter Plc. 25-04-2025
103 Erelzi Authorised etanercept Arthritis, Psoriatic;Psoriasis;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid;Spondylitis, Ankylosing Sandoz GmbH 28-03-2018
104 Hyrimoz Authorised adalimumab Arthritis, Rheumatoid;Arthritis, Psoriatic;Spondylitis, Ankylosing;Uveitis;Hidradenitis Suppurativa;Colitis, Ulcerative;Arthritis, Juvenile Rheumatoid;Crohn Disease;Skin Diseases, Papulosquamous Sandoz GmbH 26-07-2018
105 Livogiva Authorised teriparatide Osteoporosis Theramex Ireland Limited 06-01-2021
106 Eydenzelt Authorised aflibercept Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization Celltrion Healthcare Hungary Kft. 27-03-2025
107 Izamby Authorised denosumab Bone Resorption;Osteoporosis;Osteoporosis, Postmenopausal Mabxience Research SL 25-04-2025
108 Benepali Authorised etanercept Arthritis, Psoriatic;Arthritis, Rheumatoid;Psoriasis Samsung Bioepis NL B.V. 06-02-2018
109 Rolcya Authorised denosumab Osteoporosis;Osteoporosis, Postmenopausal;Bone Resorption Sandoz GmbH 23-05-2025
110 Jubbonti Authorised denosumab Osteoporosis;Osteoporosis, Postmenopausal;Bone Resorption Sandoz GmbH 22-03-2024

Get in Touch

Ready to transform your strategic intelligence? Let's talk

Subscribe to Our Newsletter

Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.